The first metal-based paullone derivative with high antiproliferative activity in vitro

9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6(5H)-one, kenpaullone, which displays similarities in the activity profile to flavopiridol, was modified by chemical transformations at the lactam unit to provide a peripheral binding site able to accommodate metal ions. The first metal-based paullone has been prepared and characterized by single-crystal X-ray diffraction methods, solid-state cross-polarization magic angle spinning 13C NMR spectroscopy, electrospray ionization mass spectra, and electronic spectra. The gallium complex [GaL2]Cl.2.5H2O, the metal-free ligand (HL), and the starting compound used for the preparation of HL were assessed in vitro for their cytotoxicity in a panel of human tumor cell lines. The gallium complex was found to be 1.5-18-fold more cytotoxic than HL, with an average IC50 value of 2.0 microM.     

Mechanistic insights into the chemistry of RuII complexes containing Cl and DMSO ligands

Two new isomers trans,mer-[RuIICl2(bpea)(DMSO)], 2a, and cis,fac-[RuIICl2(bpea)(DMSO)], 2b, (bpea = N,N-bis(2-pyridylmethyl)ethylamine), as well as the bis-DMSO complex trans,fac-[RuIICl(bpea)(DMSO)2]Cl, 3, have been synthesized and characterized by cyclic voltammetry and UV-vis and 1D and 2D NMR spectroscopy in solution. Their solid-state structure has also been solved by means of single-crystal X-ray diffraction analysis. All the three complexes display a ruthenium metal center possessing a distorted-octahedral type of coordination, where the bpea ligand is coordinated in a meridional fashion in 2a and in a facial fashion in 2b and 3. The isomer 2a is the kinetically favored and thus can be thermally converted into 2b, that is the thermodynamically favored one. A thorough kinetic analysis strongly points toward a dissociative mechanism, where in the first step a chloro ligand is removed from the metal coordination sphere, followed by a geometric rearrangement before the chloro ligand coordinates again, generating the final complex. DFT calculations agree with the experimental data for the proposed mechanism and allow us to further characterize the mechanism of the 2a --> 2b rearrangement by obtaining the intermediates and transition state.     

New synthetic approach to paullones and characterization of their SIRT1 inhibitory activity

A series of 7,12-dihydroindolo[3,2-d][1]benzazepine-6(5H)-ones (paullones) substituted at C9/C10 (Br) and C2 (Me, CF(3), CO(2)Me) have been synthesized by a one-pot Suzuki-Miyaura cross-coupling of an o-aminoarylboronic acid and methyl 2-iodoindoleacetate followed by intramolecular amide formation. Other approaches to the paullone scaffold based on Pd-catalyzed C-H activation were unsuccessful. In vitro enzymatic assay with recombinant human SIRT-1 indicated a strong inhibitory profile for the series, in particular the analogue with a methoxycarbonyl group at C2 and a bromine at C9. These compounds are, in general, inducers of granulocyte differentiation of the U937 acute leukemia cell line and cause a marked increase in pre-G1 of the cell cycle.     

Synthesis, crystal structures, and reactivity of osmium(II) and -(IV) complexes containing a dithioimidodiphosphinate ligand

Reduction of trans-[OsL2(O)2] (1) (L-=[N(i-Pr2PS)2]-) with hydrazine hydrate afforded a dinitrogen complex 2, possibly "[OsL2(N2)(solv)]" (solv=H2O or THF), which reacted with RCN, R'NC, and SO2 to give trans-[OsL2(RCN)2] (R=Ph (3), 4-tolyl (4), 4-t-BuC6H4 (5)), trans-[OsL2(R'NC)2] (R'=2,6-Me2C6H3 (xyl) (6), t-Bu (7)), and [Os(L)2(SO2)(H2O)] (8) complexes, respectively. Protonation of compounds 2, 3, and 6 with HBF4 led to formation of dicationic trans-[Os(LH)2(N2)(H2O)][BF4]2 (9), trans-[Os(LH)2(PhCN)2][BF4]2 (10), and trans-[Os(LH)2(xylNC)2][BF4]2 (11), respectively. Treatment of 1 with phenylhydrazine and SnCl2 afforded trans-[OsL2(N2Ph)2] (12) and trans-[OsL2Cl2] (13), respectively. Air oxidation of compound 2 in hexane/MeOH gave the dimethoxy complex trans-[OsL2(OMe)2] (14), which in CH2Cl2 solution was readily air oxidized to 1. Compound 1 is capable of catalyzing aerobic oxidation of PPh3, possibly via an Os(IV) intermediate. The formal potentials for the Os-L complexes have been determined by cyclic voltammetry. The solid-state structures of compounds 4, 6, cis-8, 13, and 14 have been established by X-ray crystallography.     

Conjugation of organoruthenium(II) 3-(1H-benzimidazol-2-yl)pyrazolo[3,4-b]pyridines and indolo[3,2-d]benzazepines to recombinant human serum albumin: a strategy to enhance cytotoxicity in cancer cells

Following our strategy of coupling cyclin-dependent kinase (Cdk) inhibitors with organometallic moieties to improve their physicochemical properties and bioavailability, five organoruthenium complexes (1c-5c) of the general formula [RuCl(η(6)-arene)(L)]Cl have been synthesized in which the arene is 4-formylphenoxyacetyl-η(6)-benzylamide and L is a Cdk inhibitor [3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines (L1-L3) and indolo[3,2-d]benzazepines (L4 and L5)]. All of the compounds were characterized by spectroscopic and analytical methods. Upon prolonged standing (2-3 months) at room temperature, the dimethyl sulfoxide (DMSO) solutions of 1c and 2c(-HCl) afforded residues, which after recrystallization from EtOH and EtOH/H(2)O, respectively, were shown by X-ray diffraction to be cis,cis-[Ru(II)Cl(2)(DMSO)(2)(L1)]·H(2)O and mer-[Ru(II)Cl(DMSO)(3)(L2-H)]·H(2)O. Compound 5c, with a coordinated amidine unit, undergoes E/Z isomerization in solution. The antiproliferative activities and effects on the cell cycle of the new compounds were evaluated. Complexes 1c-5c are moderately cytotoxic to cancer cells (CH1, SW480, A549, A2780, and A2780cisR cell lines). Therefore, in order to improve their antiproliferative effects, as well as their drug targeting and delivery to cancer cells, 1c-5c were conjugated to recombinant human serum albumin, potentially exploiting the so-called "enhanced permeability and retention" effect that results in the accumulation of macromolecules in tumors. Notably, a marked increase in cytotoxicity of the albumin conjugates was observed in all cases.     

Synthesis, characterization, and reactivity of iron trisamidoamine complexes that undergo both metal- and ligand-centered oxidative transformations

Functional systems that combine redox-active metals and noninnocent ligands are no longer rare chemical oddities; they are instead emerging as significant components of catalytic and enzymatic reactions. The present work examines the synthetic and functional aspects of iron compounds ligated by a family of new trisamidoamine ligands of the type [(RNC6H4)3N]3- (L1). When R is the electron-rich 4-t-Bu-Ph moiety, the ligand can undergo oxidative rearrangement and store oxidizing equivalents under specific conditions. Starting ferrous complexes of the general formula [(L1)FeIIsolv]- (solv=CH3CN, dimethylformamide) can be easily oxidized (a) by dioxygen to afford the corresponding [(L1)FeIIIOH]- complexes, featuring several cases of terminal hydroxo units, and (b) by organochlorides (R-Cl) to provide [(L1)FeIIIsolv] congeners and coupled R-R products. Efforts to synthesize [(L1)FeIII-O-FeIII(L1)]2- by using [Cl3FeIII-O-FeIIICl3]2- indicate that intrinsic FeIIICl units can oxidatively rearrange the ligand to afford [(L1re)(Cl)FeII][Et4N]2, although the oxidizing equivalent is not retained. Compound [(L1re)(Cl)FeII][Et4N]2 can be further oxidized to [(L1re-2)(Cl)FeIII][Et4N] by CH2Cl2. Finally, oxidation of [(L1)FeIIIsolv] by FeCl3 affords [(L1reH)(Cl)FeII(micro-Cl)2FeII(Cl)(L1re-2H)], which features a similar ligand rearrangement that also gives rise to a diamagnetic, doubly oxidized moiety. These results underscore the complexity of chemical transformations available to systems in which both the metal and the ligand are redox-active entities.     

Acetonimine and 4-imino-2-methylpentan-2-amino platinum(II) complexes: synthesis and in vitro antitumor activity

The reaction of [Pt(dmba)(PPh3)Cl] [where dmba = N,C-chelating 2-(dimethylaminomethyl)phenyl] with aqueous ammonia in acetone in the presence of AgClO4 gives the acetonimine complex [Pt(dmba)(PPh3)(NH=CMe2)]ClO4 (1). The reaction of [Pt(dmba)(DMSO)Cl] with aqueous ammonia in acetone in the presence of AgClO4 gives a mixture of [Pt(dmba)(NH=CMe2)2]ClO4 (2) and [Pt(dmba)(imam)]ClO4 (3a) (where imam = 4-imino-2-methylpentan-2-amino). [Pt(dmba)(DMSO)Cl] reacts with [Ag(NH=CMe2)2]ClO4 in a 1:1 molar ratio to give [Pt(dmba)(DMSO)(NH=CMe2)]ClO4 (4). The reaction of [Pt(dmba)(DMSO)Cl] with 20% aqueous ammonia in acetone at 70 degrees C in the presence of KOH gives [Pt(dmba)(CH2COMe)(NH=CMe2)] (5), whereas the reaction of [Pt(dmba)(DMSO)Cl] with 20% aqueous ammonia in acetone in the absence of KOH gives [Pt(dmba)(imam)]Cl (3b). The reaction of [NBu4]2[Pt2(C6F5)4(mu-Cl)2] with [Ag(NH=CMe2)2]ClO4 in a 1:2 molar ratio produces cis-[Pt(C6F5)2(NH=CMe2)2] (6). The crystal structures of 1 x 2 Me2CO, 2, 3a, 5, and 6 have been determined. Values of IC50 were calculated for the new platinum complexes against a panel of human tumor cell lines representative of ovarian (A2780 and A2780 cisR) and breast cancers (T47D). At 48 h incubation time complexes 1, 4, and 5 show very low resistance factors against an A2780 cell line which has acquired resistance to cisplatin. 1, 4, and 5 were more active than cisplatin in T47D (up to 30-fold in some cases). The DNA adduct formation of 1, 4, and 5 was followed by circular dichroism and electrophoretic mobility.     

Highly electrophilic (salen)ruthenium(VI) nitrido complexes

A series of cationic ruthenium(VI) nitrido species containing the cyclohexyl-bridged salen ligand (L) and its derivatives, [RuVI(N)(L)]+, have been prepared by treatment of [NBun4][RuVI(N)Cl4] with H2L in methanol. The structure of [RuVI(N)(L)](ClO4) (1a) has been determined by X-ray crystallography, d(RuN) = 1.592 A. In solvents such as DMF or DMSO, [RuVI(N)(L)]+ undergoes a facile N...N coupling reaction at room temperature to produce N2 and [RuIII(L)(S)2]+ (S = solvent). 1a reacts rapidly with secondary amines to produce diamagnetic RuIV-hydrazido(1-) species, [RuIV(N(H)NR2)(L)(HNR2)]+. The reaction with morpholine is first order in RuVI and second order in morpholine with k(CH3CN, 25 degrees C) = 2.08 x 106 M-2 s-1. This rate constant is over 4 orders of magnitude larger than that of the corresponding reaction of the electrophilic osmium nitride, trans-[OsVI(N)(tpy)(Cl)2]+, with morpholine. The structure of [Ru(NHNC4H8)(L)(NHC4H8)](PF6)2 has been determined by X-ray crystallography, the Ru-N(hydrazido) distance is 1.940 A, and the Ru-N-N angle is 129.4 degrees .     

2-benzazepines. 10 [1]. New d-fused 2-benzazepines

Pyrano[3,2-d][2]benzazepines were synthesized by reaction of the beta-dimethylamino unsaturated ketone 1 with malonic ester or the anion of t-butyl acetate. Conversion of the pyrano derivative to the pyrido[3,2-d]-[2]benzazepine was achieved in low yield. A pyrrolo[3,2-d][2]benzazepine was prepared via an oxazepino-[6,7-d][2]benzazepine which was obtained by reaction of 1 with the anion of ethyl isocyanoacetate.     

Synthesis of 3-Substituted Pyrido[4′,3′:4,5]thieno[2,3-d]pyrimidines and Related Fused Thiazolo Derivatives

New ethyl 3-(substituted)-4-oxo-2-thioxo-1,2,3,4,5,6,7,8-octahydropyrido[4',3':4,5]thieno-[2,3-d]pyrimidine-7-carboxylates ( 3a , b ), ( 6 ),( 11-13 ), ethyl 3-methyl-5-oxo-2,3,6,9-tetrahydro 5 H -pyrido[4',3':4,5]thieno[2,3-d][1,3]thiazolo[3,2-a]pyrimidine-8(7H)-carboxylate ( 4 ), and ethyl 2-methyl-5-oxo-2,3,6,9-tetrahydro-5 H -pyrido[4',3':4,5]thieno[2,3-d][1,3]thiazolo[3,2-a]-pyrimidine-8(7H)-carboxylate ( 8 ) have been synthesized from diethyl 2-isothiocyanato-4,5,6,7-tetrahydrothieno[2,3-c]pyridine-3,6-dicarboxylate 1. The structure of these compounds as well as their intermediates have been established by their spectral data.     

Synthesis and structural peculiarities of gallium Complexes with novel paullone derivatives

9-Bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6-ylhydrazine was reacted with 2-acetylpyridine to give a Schiff base as a potential tridentate ligand. The reaction of this ligand with gallium chloride afforded complexes of 1:1 and 2:1 stoichiometry. The results of X-ray diffraction studies of the ligand and both gallium complexes are reported and compared with the data for a related gallium complex with a Schiff base obtained from 9-bromo-7,12-dihydroindolo[3,2-d][1]benzazepin-6-ylhydrazine and 2-hydroxybenzaldehyde.      

Syntheses and reactivity studies of solvated dirhenium acetonitrile complexes

Fully and partially solvated triply-bonded [Re2]4+ complexes have been synthesized and their X-ray structures are described. A fully solvated dirhenium salt with BArf [tetrakis(3,5-bis(trifluoromethyl)phenyl)borate] as the counter anion [Re2(CH3CN)10][BArf]4 () has been characterized. The solubility of the complex in CH2Cl2 and THF in addition to CH3CN offers the possibility of improved reactivity. The structure of [Re2(micro-O)(CH3CN)10][BF4]4 () that possesses a linear [Re(III)-O-Re(III)]4+ unit is reported. Protonation reactions of cis-Re2Cl2(dppm)2(O2CCH3)2 and trans-Re2Cl4(dppm)2 with HBF4.Et2O in acetonitrile afforded cis and trans [Re2(dppm)2(CH3CN)6][BF4]4 ( and ), respectively. Prolonging the reaction time, however, does not lead to fully solvated complex [Re2(CH3CN)10][BF4]4. The neutral nitrogen donor ligands pynp (2-(2-pyridyl)-1,8-naphthyridine) and tznp (2-(2-thiazolyl)-1,8-naphthyridine) react readily with [Re2(CH3CN)10][BF4]4 to provide trans-[Re2(pynp)2(CH3CN)4][BF4]4 and trans-[Re2(tznp)2(CH3CN)4][BF4]4. The X-ray structures trans-[Re2(pynp)2(CH3CN)4][BF4]4 () and trans-[Re2(tznp)2(CH3CN)4][BF4]3[PF6] () have been determined.     

Synthesis, structure, spectroscopic properties, and antiproliferative activity in vitro of novel osmium(III) complexes with azole heterocycles

Reactions of (H 2azole) 2[OsCl 6], where Hazole = pyrazole, Hpz, ( 1), indazole, Hind, ( 2), imidazole, Him, ( 3) and benzimidazole, Hbzim, ( 4) with the corresponding azole heterocycle in 1:4 molar ratio in boiling isoamyl alcohol or hexanol-1 afforded novel water-soluble osmium(III) complexes of the type trans-[OsCl 2(Hazole) 4]Cl, where Hazole = Hpz ( 5a), Hind ( 6a), Him ( 7a), and Hbzim ( 9a) in 50-70% ( 5a, 7a, 9a) and 5% ( 6a) yields. The synthesis of 7a was accompanied by a concurrent reaction which led to minor formation (<4%) of cis-[OsCl 2(Him) 4]Cl ( 8). The complexes were characterized by elemental analysis, IR spectroscopy, UV-vis spectroscopy, ESI mass spectrometry, cyclic voltammetry, and X-ray crystallography. 5a, 7a, and 9a were found to possess remarkable antiproliferative activity in vitro against A549 (non-small cell lung carcinoma), CH1 (ovarian carcinoma), and SW480 (colon carcinoma) cells, which was compared with that of related ruthenium compounds trans-[RuCl 2(Hazole) 4]Cl, where Hazole = Hpz (5b), Hind (6b), Him (7b), and Hbzim (9b).     

Syntheses, structures, and electrochemical properties of inclusion compounds of cucurbit[8]uril with cobalt(III) and nickel(II) complexes

Inclusion compounds of a macrocyclic cavitand cucurbit[8]uril (CB[8]) with cobalt(III) and nickel(II) complexes of 1,3-diaminopropane (tn) and 1,3-diamino-2-propanol (tmOH) { trans-[Co(tn) 2Cl 2]@CB[8]}Cl.14H 2O ( 1), { trans-[Co(tmOH)(tmO)]@CB[8]}Cl 2.22H 2O ( 2), and { trans-[Ni(tmOH) 2]@CB[8]}Cl 2.22H 2O ( 3) were synthesized and characterized by X-ray single crystal analysis, IR spectroscopy, ESI-MS, and by solid-state stripping voltammetry. The encapsulation of trans-[Co(tn) 2Cl 2] (+) within the cavity of CB[8] stabilizes the complex toward ligand substitution reactions in aqueous solution. The electrochemical study demonstrates that CB[8] prefers the oxidized species in trans-[Co(tn) 2Cl 2] (+)/ trans-[Co(tn) 2Cl 2] (0) and trans-[Co(tmO)(tmOH) 2] (2+)/ trans-[Co(tmO)(tmOH) 2] (+) redox couples, but stabilizes the reduced form trans-[Ni(tmOH) 2] (2+) against the oxidized species. The reversibility of voltammogram shapes evidence that for the inclusion compounds 1- 3 electron transfer reactions proceed within the cavity of the host.     

Dependence of field switched ordered arrays of dinuclear mixed-valence complexes on the distance between the redox centers and the size of the counterions

trans-[(H(2)NCH(2)CH(2)C triple bond N)(dppe)(2)Ru(C triple bond C)(6)Ru(dppe)(2)(N triple bond CCH(2)CH(2)NH(2))][PF(6)](2), 2[PF(6)](2), a derivative of trans-[Cl(dppe)(2)Ru(C triple bond C)(6)Ru(dppe)(2)Cl] functionalized for binding to a silicon substrate, has been prepared and characterized spectroscopically, electrochemically, and with a solid state, single-crystal structure determination. Covalent binding via reaction of one amine group to a boron-doped, smooth Si-Cl substrate is verified by XPS measurements and surface electrochemistry. Vertical orientation is demonstrated by film thickness measurements. Synthesis of the 2[PF(6)](3) mixed-valence complex on the surface is established by electrochemical techniques. Measurement of the ac capacitance of the film at 1 MHz as a function of voltage across the film with a pulse-counter pulse technique demonstrates controlled electric field generation of the two stable mixed-valence forms differing in the spatial location of one electron, that is, switching. As compared to [trans-Ru(dppm)(2)(C triple bond CFc)(NCCH(2)CH(2)NH(2))][PF(6)][Cl], 1[PF(6)][Cl], the magnitude of the capacitance signal per complex observed on switching is shown to increase with increasing distance between the metal centers. Additional experiments on 1[X][Cl] show that the potential for switching 1[X][Cl] increases in the order [X](-) = [SO(3)CF(3)](-) < [PF(6)](-) < [Cl](-). A simple electrostatic model suggests that the smaller is the counterion, the greater is the perturbation of the metal sites and the larger is the barrier for switching.     

Irreversible and reversible formation of a [2]rotaxane containing platinum(II) complex with an N-alkyl bipyridinium ligand as the axis component

An N-Alkyl bipyridinium having a polymethylene chain and a bulky aryl group at the end, [4,4'-bpy-N-(CH2)10OC6H(3)-3,5-tBu2]Cl (Cl), reacts with K[PtCl3(dmso)] to produce the Pt complex with the N-alkyl bipyridinium ligand [Cl2(dmso)Pt{4,4'-bpy-N-(CH2)10OC6H(3)-3,5-tBu2}][PtCl3(dmso)] as a 6:1 mixture of trans and cis isomers ([trans-][PtCl3(dmso)] and [cis-][PtCl3(dmso)]). Addition of alpha-cyclodextrin (alpha-CD) to a solution of Cl in dmso-d6/D2O (3:1) forms [2]pseudorotaxane [{4,4'-bpy-N-(CH2)10OC6H(3)-3,5-tBu2}.(alpha-CD)]Cl (Cl) which is equilibrated with Cl and alpha-CD in solution. The reaction of K[PtCl3(dmso)] with Cl affords the [2]rotaxane [trans-Cl2(dmso)Pt{4,4'-bpy-N-(CH2)10OC6H(3)-3,5-tBu2}.(alpha-CD)][PtCl3(dmso)] ([trans-][PtCl3(dmso)]) which contains alpha-CD and [trans-][PtCl3(dmso)] as the cyclic and axis components, respectively. Dissolution of a mixture of [trans-][PtCl3(dmso)], [cis-][PtCl3(dmso)] and alpha-CD in dmso-d6/D2O (3:1) forms a mixture of the rotaxanes containing [trans--d6][PtCl3(dmso)] and [cis--d6][PtCl3(dmso)]. The reaction involves partial dissociation of the bipyridinium from Pt of [trans-][PtCl3(dmso)] or [cis-][PtCl3(dmso)] to yield [PtCl3(dmso)] and formation of pseudorotaxane with alpha-CD, followed by recoordination of the bipyridinium to the Pt. The reversible formation of the Pt-N coordination bond is studied in a dmso solution of the N-butyl compounds [trans-Cl2(dmso)Pt{4,4'-bpy-N-nBu}][PtCl3(dmso)] ([trans-][PtCl3(dmso)]).     

Solid- and solution phase transformations in novel hybrid iodoplumbate derivatives templated by solvated yttrium complexes

Solvated yttrium iodide precursors [Y(L)8]I3 [L = dimethylformamide (DMF) or dimethylsulfoxide (DMSO)], prepared in situ by stirring YI3(Pr(i)OH)4 in DMF/DMSO, react with 3 equiv of PbI2 in the presence of NH4I to give novel hybrid derivatives based on either a one-dimensional (1D) straight chain, [Y(DMF)8][Pb3(mu-I)9](1infinity) x DMF (1), or discrete pentanuclear iodoplumbates, [Y(DMSO)8]2[(DMSO)2Pb5(mu3-I)2(mu-I)8I6] (2a). The complex 2a and a closely related [Y(DMSO)8][Y(DMSO)7(DMF)][(DMSO)2Pb5(mu3-I)2(mu-I)8I6] (2b) were obtained in good yield by solution phase transformation of 1 in DMSO under slight different conditions. Derivatives 1 and 2 also undergo unique solid-state transformation in a confined environment of paratone to give 1D polymers based on zigzag iodoplumbate chains; crystals of 1 transform into [Y(DMF)6(H2O)2][Pb3(mu3-I)(mu-I)7I](1infinity) (3) via an exchange reaction, whereas those of 2a and 2b are converted into [Y(DMSO)7][Pb3(mu3-I)(mu-I)7I](1infinity) (4) via a decomposition pathway. The trifurcate H-bonding between water ligands on yttrium cation and iodide of the iodoplumbate anion plays a pivotal role in transforming the straight 1D polymeric Pb-I chain of 1 into a zigzag chain in 3. The thermogravimetry-differential thermal analysis studies indicate that complexes with DMF ligands are thermally more stable than those with DMSO ones, the mixed DMF-H2O ligand complex 3 being the most stable one because of the presence of strong H-bonding. Diffuse-reflectance UV-visible spectral analyses of 1-4 show an optical band gap in the 1.86-2.54 eV range, indicating these derivatives as potential semiconductors. In contrast to non-emissive 3 and 4, derivatives 1, 2a, and 2b show remarkable luminescent emission with peak maxima at 703 nm, assigned as an iodine 5p-lead 6s to lead 6p charge transfer (XM-M-CT).     

Mixed ligand cobalt(II) picolinate complexes: synthesis, characterization, DNA binding and photocleavage

Complexes of the type [Co(pic)(2)(NN)], where pic = picolinate, NN = dipyrido[3,2-d:2',3'-f]quinoxaline (dpq) (4) and 4b,5,7,7a-tetrahydro-4b,7a-epiminomethanoimino-6H-imidazo[4,5-f][1,10]-phenanthroline-6,13-dione (bipyridyl-glycoluril) (bpg) (6) have been synthesized and characterized by elemental analysis, IR, UV-vis, NMR and ESI-MS spectroscopy and thermogravimetic analysis (TGA). Their physicochemical properties are compared with previously synthesized complexes, where NN = (H(2)O)(2) (1), 2,2'-bipyridine (bpy) (2), 1,10-phenanthroline (phen) (3) and dipyrido[3,2-a:2',3'-c]phenazine (dppz) (5). The crystal structures of the complexes 4-6 were solved by single-crystal X-ray diffraction. The complexes 4 and 5 crystallize from a mixture of chloroform and methanol in monoclinic and orthorhombic crystal systems, respectively, whereas complex 6 crystallizes from dimethyl sulfoxide (DMSO) in a tetragonal crystal system. The coordination sphere consists of two oxygen atoms and two nitrogen atoms from the two picolinates and two nitrogen atoms from the dpq, dppz or bpg ligand, respectively. Co(ii)/Co(iii) oxidation potentials have been determined by cyclic voltammetry. The DNA binding of complexes 1-5 has been investigated using thermal melting, fluorescence quenching and viscosity measurements, which indicate the partial intercalation of complex 5 with an apparent binding constant (k(app)) of 8.3 × 10(5) M(-1). DNA cleavage studies of complexes 1-5 have been investigated using gel electrophoresis in the presence of H(2)O(2) as an oxidizing agent and also by photoirradiation at 365 nm. The mechanistic investigations suggest that singlet oxygen ((1)O(2)) is the major species involved in the DNA cleavage by these complexes. The structures of complexes 2-6 were optimized with density functional theory (DFT) method (B3LYP/6-31G(d,p)). The low vertical ionization potential values indicate photoredox pathways for the DNA cleavage activity by complexes 4 and 5, which is corroborated by DNA cleavage experiments.     

Further study of the reaction of Fe2+ with CN-: synthesis and characterization of cis and trans [FeII,III(CN)4L2]n- complexes

The reaction of Fe2+ with CN-, which was first performed in 1704, has been used to synthesize a new series of basic [FeII,III(CN)4L2]n- complexes, where L is a monodentate ligand. trans-Na2[FeII(CN)4(DMSO)2] and cis-[NEt4]2[FeII(CN)4(pyridine)2] are synthesized by the direct reaction of FeCl2 with 4 equiv of CN- in DMSO or pyridine. Air oxidation of the latter compound gives cis-[NEt4][FeIII(CN)4(pyridine)2]. The non-cyanide ligands in these complexes undergo facile ligand exchange reactions with solvent. Reaction of cis-[NEt4]2[FeII(CN)4(pyridine)2] with CO at room temperature gives trans-[NEt4]2[FeII(CN)4(pyridine)(CO)].     

Galanthamine analogs: 6H-benzofuro[3a,3,2,-e,f][1]benzazepine and 6H-benzofuro[3a,3,2-e,f][3]benzazepine

The known cholinesterase inhibitory capability of the Amarylidaceae alkaloid galanthamine prompted preparation of analogs in which the position of the nitrogen within the azepine ring is altered. The analogs 6H-benzofuro[3a,3,2-e,f][1]benzazepine and 6H-benzofuro[3a,3,2-e,f][3]benzazepine were prepared in 19 and 2.5%, respectively, following Kametani and Shimizu approaches, respectively. The aniline derivative 6H-benzofuro[3a,3,2-e,f][1]benzazepine failed to undergo most of the reactions typical for galanthamine. Thus, it neither oxidized to the analogous narwedine, nor epimerized to the analogous epigalanthamine, nor reduced to the lycoramine analog, under the conditions used for galanthamine.